Abstract
By analyzing data from 68 hypothyroid patients ranging in age from 15 to 75 years who had been maintained in a euthyroid state for at least a year with oral levothyroxine sodium therapy, we attempted to determine whether there was a correlation between L-thyroxine dose and body weight or patient age. The mean replacement dose of L-thyroxine was 186 μg a day ±69.6 or 2.76 μg per kg of body weight a day ±0.82. There was a significant correlation between L-thyroxine dose and body weight (P<.001), but due to the small number of patients studied who were older than 65 years of age, no correlation was noted between L-thyroxine dose and age.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abbassi V., Aldige C. Evaluation of sodium L-thyroxine (T4) requirement in replacement therapy of hypothyroidism. J Pediatr. 1977 Feb;90(2):298–301. doi: 10.1016/s0022-3476(77)80656-2. [DOI] [PubMed] [Google Scholar]
- Evered D., Young E. T., Ormston B. J., Menzies R., Smith P. A., Hall R. Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J. 1973 Jul 21;3(5872):131–134. doi: 10.1136/bmj.3.5872.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GREGERMAN R. I., GAFFNEY G. W., SHOCK N. W., CROWDER S. E. Thyroxine turnover in euthyroid man with special reference to changes with age. J Clin Invest. 1962 Nov;41:2065–2074. doi: 10.1172/JCI104664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hays M. T. Absorption of oral thyroxine in man. J Clin Endocrinol Metab. 1968 Jun;28(6):749–756. doi: 10.1210/jcem-28-6-749. [DOI] [PubMed] [Google Scholar]
- Krenning E. P., Docter R., Visser T. J., Hennemann G. Replacement therapy with L-thyroxine: serum thyroid hormone and thyrotropin levels in hypothyroid patients changing from desiccated thyroid to pure thyroxine substitution therapy. Neth J Med. 1981;24(1):1–5. [PubMed] [Google Scholar]
- Maeda M., Kuzuya N., Masuyama Y., Imai Y., Ikeda H. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism. J Clin Endocrinol Metab. 1976 Jul;43(1):10–17. doi: 10.1210/jcem-43-1-10. [DOI] [PubMed] [Google Scholar]
- Nilsson G., Pettersson U., Levin K., Hughes R. Studies on replacement and suppressive dosages of 1-thyroxine. Acta Med Scand. 1977;202(4):257–260. doi: 10.1111/j.0954-6820.1977.tb16823.x. [DOI] [PubMed] [Google Scholar]
- Oddie T. H., Meade J. H., Jr, Fisher D. A. An analysis of published data on thyroxine turnover in human subjects. J Clin Endocrinol Metab. 1966 Apr;26(4):425–436. doi: 10.1210/jcem-26-4-425. [DOI] [PubMed] [Google Scholar]
- Rezvani I., DiGeorge A. M. Reassessment of the daily dose of oral thyroxine for replacement therapy in hypothyroid children. J Pediatr. 1977 Feb;90(2):291–297. doi: 10.1016/s0022-3476(77)80655-0. [DOI] [PubMed] [Google Scholar]
- Rosenbaum R. L., Barzel U. S. Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med. 1982 Jan;96(1):53–55. doi: 10.7326/0003-4819-96-1-53. [DOI] [PubMed] [Google Scholar]
- Stock J. M., Surks M. I., Oppenheimer J. H. Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation. N Engl J Med. 1974 Mar 7;290(10):529–533. doi: 10.1056/NEJM197403072901001. [DOI] [PubMed] [Google Scholar]
- Stoffer S. S., Szpunar W. E. Potency of brand name and generic levothyroxine. JAMA. 1980 Oct 10;244(15):1704–1705. [PubMed] [Google Scholar]
- Stoffer S. S., Szpunar W. E. Potency of levothyroxine products. JAMA. 1984 Feb 3;251(5):635–636. [PubMed] [Google Scholar]
- Surks M. I., Schadlow A. R., Stock J. M., Oppenheimer J. H. Determination of iodothyronine absorption and conversion of L-thyroxine (T 4 ) to L-triiodothyronine (T 3 ) using turnover rate techniques. J Clin Invest. 1973 Apr;52(4):805–811. doi: 10.1172/JCI107244. [DOI] [PMC free article] [PubMed] [Google Scholar]